Independent Panel: EPA Underestimates Atrazine’s Cancer Risk

Henry Arden/Cultura/Zuma

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Atrazine is the second most widely used pesticide on US farms. According to its maker, the Swiss agrichemical giant Syngenta, US sales of it are booming. Does it cause cancer?

The EPA, which regulates pesticide use, has been operating under the assumption that the chemical is “not likely to be a human carcinogen.” But in 2009, the agency launched what it called a “comprehensive new evaluation of the pesticide atrazine to determine its effects on humans.” As part of the process, it charged a panel made up of independent scientists and public health experts to “evaluate the pesticide’s potential cancer and non-cancer effects.”

Last week, the EPA released the minutes of the panel’s final meeting, which took place July 26-28. Its conclusions were stark. The panel criticized the EPA for lumping all forms of cancer together in its atrazine assessment, noting that “it would be useful and appropriate to make conclusions for individual cancers as opposed to making a blanket determination for cancer in general.” It then gave a list of cancers for which there is “suggestive evidence of carcinogenic potential”: ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia, and thyroid cancer. For other cancers—prostate cancer, breast cancer, liver cancer, esophageal cancers, and childhood cancers—the panel found that “there is inadequate evidence” to determine whether or not atrazine is a cause.

At another point in the minutes, the panel pointed to “strong” epidemiological evidence linking atrazine to thyroid cancer and “suggestive” evidence linking it to ovarian cancer. “Many on the Panel believed that the epidemiology data failed to provide compelling evidence that atrazine is not carcinogenic,” the minutes stated. 

The panel’s takeaway message:

The Panel recommended adjusting the conclusion that atrazine is unlikely to be carcinogenic to humans to “inadequate information to assess carcinogenic potential.”

To put the panel’s conclusion in plain English, the agency had been understating the cancer risk posed by atrazine. That can bring no comfort to hundreds of thousands of people who live in the agriculture-intensive regions of the Midwest and South. That’s because, as this 2010 analysis of US Geological Survey data by the Natural Resources Defense Council shows, surface water and drinking water there are “pervasively contaminated with atrazine.” What’s worse, levels often spike during times of year when farmers apply the chemical, exposing people to atrazine levels at or above the EPA’s accepted limit of 3 parts per billion.

When EPA announced its review of atrazine in 2009, its press release described the project like this:

The U.S. Environmental Protection Agency is launching this year a comprehensive new evaluation of the pesticide atrazine to determine its effects on humans. At the end of this process, the agency will decide whether to revise its current risk assessment of the pesticide and whether new restrictions are necessary to better protect public health.

Now that the panel has completed its final meeting, what’s next for the EPA’s review of atrazine? Will the agency ban the chemical, which in addition to its carcinogenic potential is also strongly suspected of being an endocrine disruptor? Or will it declare a moratorium on its use, pending more research?

Apparently, the agency plans to do nothing at all, at least for the time being. I contacted the EPA press office to find out the next step in the process. A spokesperson would tell me only that the agency would not begin to consider changing atrazine’s actual regulatory status until 2013—and could give me no timeline on how long that process would take. In the mean time, farmers will continue dumping 76 million pounds of it onto farm land annually, to the delight of Syngenta shareholders. 

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate